About
Company Profile

Founded in 2013, Shanghai Celliver Biotechnology Co., Ltd. is located in Zhangjiang High Tech core Park, rooted in the field of cell and regenerative medicine, focusing on providing new cell therapy solutions for patients with liver disease, and committed to becoming a leader in the field of cell therapy for international liver disease.

2020. 06

A Round of financing completed

2020.04

Preclinical study of Aliver™ extracorporeal bioartificial liver accepted by Science Translational Medicine

2019.06

New GMP manufacturing facility launched

2018.10

Report a breakthrough in in vitro expansion of human hepatocytes

2018.06

PreA round of financing completed

2017.08

Formal operation

公司简介

Shanghai Celliver Biotechnology Co., Ltd. was established in Zhangjiang High-tech Park in 2013, rooted in the field of cell and regenerative medicine, focusing on developing life-saving cell therapies, and is committed to becoming a worldwide pioneer company leading cell-based treatment for many medically refractory liver diseases including NASH, cirrhosis and end-stage liver diseases.